Arcosa Stock Forecast, Price & News

Arcosa's stock was trading at $37.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACA stock has increased by 68.7% and is now trading at $62.48.
View which stocks have been most impacted by COVID-19.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Arcosa stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACA, but not buy additional shares or sell existing shares.
View analyst ratings for Arcosa or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Arcosa a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Arcosa wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

6,978 employees have rated Arcosa CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Arcosa's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Arcosa.

Arcosa, Inc. (NYSE:ACA) issued its quarterly earnings results on Monday, November, 2nd. The company reported $0.68 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.65 by $0.03. The company earned $490 million during the quarter, compared to the consensus estimate of $501 million. Arcosa had a return on equity of 6.77% and a net margin of 6.09%.
View Arcosa's earnings history.

Arcosa declared a quarterly dividend on Thursday, December 3rd. Shareholders of record on Friday, January 15th will be given a dividend of $0.05 per share on Friday, January 29th. This represents a $0.20 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, January 14th.
View Arcosa's dividend history.

Arcosa pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.32%. Arcosa does not yet have a strock track record of dividend growth. The dividend payout ratio of Arcosa is 8.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Arcosa will have a dividend payout ratio of 8.37% next year. This indicates that Arcosa will be able to sustain or increase its dividend.
View Arcosa's dividend history.

7 equities research analysts have issued 12 month price objectives for Arcosa's stock. Their forecasts range from $48.00 to $61.00. On average, they expect Arcosa's stock price to reach $54.60 in the next twelve months. This suggests that the stock has a possible downside of 12.6%.
View analysts' price targets for Arcosa or view Wall Street analyst' top-rated stocks.

Some companies that are related to Arcosa include Proto Labs (PRLB), Valmont Industries (VMI), HC2 (HCHC), Gulf Island Fabrication (GIFI), TechPrecision (TPCS) and Williams Industries (WMSI).
View all of ACA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), The Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by many different institutional and retail investors. Top institutional investors include Kirr Marbach & Co. LLC IN (0.23%), Dalton Greiner Hartman Maher & Co. (0.16%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.05%), Pendal Group Limited (0.04%) and Pacer Advisors Inc. (0.03%). Company insiders that own Arcosa stock include Antonio Carrillo, Kerry S Cole, Ronald J Gafford and Valueact Capital Master Fund,.
View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Bowling Portfolio Management LLC, Crossmark Global Holdings Inc., Kirr Marbach & Co. LLC IN, Raymond James Trust N.A., Pendal Group Limited, and Sawgrass Asset Management LLC. Company insiders that have sold Arcosa company stock in the last year include Kerry S Cole, and Ronald J Gafford.
View insider buying and selling activity for Arcosa or view top insider-selling stocks.

ACA stock was acquired by a variety of institutional investors in the last quarter, including Pacer Advisors Inc..
View insider buying and selling activity for Arcosa or or view top insider-buying stocks.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACA stock can currently be purchased for approximately $62.48.

Arcosa has a market capitalization of $3.02 billion and generates $1.74 billion in revenue each year. The company earns $113.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Arcosa employs 6,275 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at 972-942-6500 or via email at [email protected]